Photo of Rama Al Hamed from X
Aug 4, 2024, 07:01
Rama Al Hamed: Allogeneic SCT in de novo core-binding factor AML in first complete remission
Rama Al Hamed, Hematology/Oncology Fellow at Herbert Irving Comprehensive Cancer Centre, shared on X:
“Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT.
Worse outcomes with consolidation with alloSCT in CR1 compared to ASCT.”
Source: Rama Al Hamed/X
Authors: Rama Al Hamed, Myriam Labopin, Depei Wu, Tobias Gedde-Dahl, Mahmoud Aljurf, Edouard Forcade, Urpu Salmenniemi, Jakob Passweg, Johan Maertens, Thomas Pabst, Jurjen Versluis, Maija Itäla-Remes, Xiao-Jun Huang, Gwendolyn Van Gorkom, Thomas Schroeder, Jaime Sanz, Didier Blaise, Péter Reményi, Urs Schanz, Jordi Esteve, Norbert-Claude Gorin, Fabio Ciceri, Mohamad Mohty
Acute Myeloid Leukemia
alloSCT
AML
cancer
Depei Wu
Didier Blaise
EBMT
Edouard Forcade
Fabio Ciceri
Gwendolyn Van Gorkom
Herbert Irving Comprehensive Cancer Centre
Jaime Sanz
Jakob Passweg
Johan Maertens
Jordi Esteve
Jurjen Versluis
Mahmoud Aljurf
Maija Itäla-Remes
Mohamad Mohty
Myriam Labopin
Norbert-Claude Gorin
OncoDaily
Oncology
Péter Reményi
Rama Al Hamed
Thomas Pabst
Thomas Schroeder
Tobias Gedde-Dahl
Urpu Salmenniemi
Urs Schanz
Xiao-Jun Huang
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18
Dec 21, 2024, 11:12
Dec 21, 2024, 11:06